THE VITALITY HEALTHSPAN FOUNDATION MISSION
The past decade has seen an explosion in technology, data, and spending in the healthcare system.
Despite major advancements in biotechnology and digital health, it still takes billions of dollars
and over a decade of work to bring a drug to market.
Our mission
is to improve healthspan research efficiency. The Vitality Healthspan Foundation supports innovative
projects that improve confidence in drug discovery, align incentives toward sharing between biomedical data stakeholders, and reducing friction in clinical study design and execution.
Epigenetic Programming has evolved into the most promising areas of healthspan research. Turn Biosciences is on the leading-edge...
Join Dr. Morgan Levine, Dr. Joris Deleen, and Nikolina Lauc to talk about how we measure how old we really are. Hosted by Max Unfried.
Senescent cells contribute to age-related diseases such as Pulmonary Diseases, Diabetes, Alzheimer’s, Cardiovascular Diseases and Cancer. Rubedo's ALEMBIC drug platform is finding targeted prodrugs to remove senescent cells when our body fails.
Researching, financing, and commercializing longevity research in an open and democratic manner.
Promoting healthy longevity for all through scientific research
3456 Paul Anka Drive
Ottawa ON K1V 9K6
Canada